BATM Advanced Communications (LSE:BVC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
BATM Advanced Communications Forward PE Ratio Related Terms
BATM Advanced Communications Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications Forward PE Ratio Chart
BATM Advanced Communications Annual Data
Trend
2015-12
2016-12
2024-12
2025-12
Forward PE Ratio
48.08
25.84
31.33
23.79
BATM Advanced Communications Semi-Annual Data
2015-12
2016-06
2016-12
2017-06
2024-12
2025-06
2025-12
Forward PE Ratio
48.08
39.22
25.84
40.00
31.33
52.50
23.79
LSE:BVC vs ISRG, BDX, MDLN: Forward PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's Forward PE Ratio falls into.
BATM Advanced Communications Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
BATM Advanced Communications (LSE:BVC) has a Forward PE Ratio of 5.00 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on BATM Advanced Communications and its competitors. According to the industry distribution chart, BATM Advanced Communications ranks #16 out of 392 companies in the Medical Devices & Instruments industry, placing it in the top 4.1%.
Is BATM Advanced Communications' Forward PE Ratio too high?
BATM Advanced Communications' current Forward PE Ratio is 5.00. The Medical Devices & Instruments industry median Forward PE Ratio is 19.17. BATM Advanced Communications' value of 5.00 is 73.9% below this industry median. Based on the distribution chart, BATM Advanced Communications ranks #16 out of 392 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BATM Advanced Communications has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' Forward PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #16 out of 392 companies for Forward PE Ratio. This places BATM Advanced Communications in the top 4% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 19.17. BATM Advanced Communications' value of 5.00 is 73.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.17, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current Forward PE Ratio of 5.00 is 73.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current Forward PE Ratio is 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (LSE:BVC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.17, compared to a current price of £0.15 — trading 14.7% below its estimated fair value. The current Forward PE Ratio is 5.00 and 73.9% below the Medical Devices & Instruments industry median of 19.17. BATM Advanced Communications' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For BATM Advanced Communications (LSE:BVC), the current Forward PE Ratio is 5.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (LSE:BVC) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.15 is trading 14.7% below its estimated GF Value™ of £0.17.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for LSE:BVC:
Forward PE Ratio: 5.00
GF Value™: £0.17 vs. price of £0.15 (14.7% below fair value)
Industry Position: 73.9% below the Medical Devices & Instruments median (#16 of 392)
No single metric tells the full story. See the LSE:BVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
40GF Score
Get the complete analysis for LSE:BVC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BVC has been successfully added to your 